SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041422
Filing Date
2023-08-10
Accepted
2023-08-10 16:36:37
Documents
92
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-20230630.htm   iXBRL 10-Q 4239379
2 EX-31.1 ortx-ex31_1.htm EX-31.1 19293
3 EX-31.2 ortx-ex31_2.htm EX-31.2 19324
4 EX-32.1 ortx-ex32_1.htm EX-32.1 15701
  Complete submission text file 0000950170-23-041422.txt   14105184

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ortx-20230630.xsd EX-101.SCH 76373
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ortx-20230630_lab.xml EX-101.LAB 557713
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ortx-20230630_pre.xml EX-101.PRE 428788
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ortx-20230630_def.xml EX-101.DEF 233325
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ortx-20230630_cal.xml EX-101.CAL 70449
86 EXTRACTED XBRL INSTANCE DOCUMENT ortx-20230630_htm.xml XML 2920704
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 231160165
SIC: 2836 Biological Products, (No Diagnostic Substances)